CSIMarket


Ani Pharmaceuticals Inc  (NASDAQ: ANIP)
Other Ticker:  
 

Ani Pharmaceuticals Inc

ANIP's Fundamental analysis








Looking into Ani Pharmaceuticals Inc growth rates, revenue grew by 44.75 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 351

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Ani Pharmaceuticals Inc faced net loss in contrast to the net income a year ago in IV. Quarter 2024

More on ANIP's Growth


Ani Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Ani Pharmaceuticals Inc realized cash reduction of $ -3.93 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.2.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.


More on ANIP's Valuation
 
 Total Debt (Millions $) 318
 Dividend TTM ($) 0.04 $
 Dividend Yield TTM (%) 0.06 %
 Revenue/Employee (TTM) $ 956,972
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 3.25
 Tangible Book Value (Per Share $) -10.23

Ani Pharmaceuticals Inc
realized net loss in trailing twelve months.

Ani Pharmaceuticals Inc realized cash outflow of $ -3.93per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.2.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.

Ani Pharmaceuticals Inc Price to Book Ratio is at 3.35 lower than Industry Avg. of 79.76. and higher than S&P 500 Avg. of 0.01

More on ANIP's Valuation

  Market Capitalization (Millions $) 1,353
  Shares Outstanding (Millions) 19
  Employees 642
  Revenues (TTM) (Millions $) 614
  Net Income (TTM) (Millions $) -19
  Cash Flow (TTM) (Millions $) -76
  Capital Exp. (TTM) (Millions $) -17
  Total Debt (Millions $) 318
  Dividend TTM ($) 0.04 $
  Dividend Yield TTM (%) 0.06 %
  Revenue/Employee (TTM) $ 956,972
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 3.25
  Tangible Book Value (Per Share $) -10.23

  Market Capitalization (Millions $) 1,353
  Shares Outstanding (Millions) 19
  Employees 642
  Revenues (TTM) (Millions $) 614
  Net Income (TTM) (Millions $) -19
  Cash Flow (TTM) (Millions $) -76
  Capital Exp. (TTM) (Millions $) -17





  Ratio
   Capital Ratio (MRQ) 2.72
  Total Debt to Equity (MRQ) 0.79
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.56
  Inventory Turnover Ratio (TTM) 1.91





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com